Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

Blood Cancer J. 2014 Feb 14;4(2):e181. doi: 10.1038/bcj.2014.5.
No abstract available